These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6488679)

  • 21. Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype.
    Shen DD; Hosler JP; Schroder RL; Azarnoff DL
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):53-68. PubMed ID: 7381691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of food on the absorption of hydralazine in man.
    Walden RJ; Hernandez R; Witts D; Graham BR; Prichard BN
    Eur J Clin Pharmacol; 1981; 20(1):53-8. PubMed ID: 7308273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects.
    Vidrio H; Tena I
    Clin Pharmacol Ther; 1980 Nov; 28(5):587-91. PubMed ID: 7438677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.
    Rashid JR; Kofi-Tsepko ; Juma FD
    East Afr Med J; 1992 Jul; 69(7):406-8. PubMed ID: 1396201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single versus multiple daily administration of hydralazine in the maintenance treatment of hypertension. Clinical and pharmacokinetic aspects.
    Henningsen NC; Hanson A; Wernersson B
    Acta Med Scand; 1982 May; 211(3):179-85. PubMed ID: 7044051
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers.
    Reece PA; Stafford I; Prager RH; Walker GJ; Zacest R
    J Pharm Sci; 1985 Feb; 74(2):193-6. PubMed ID: 3989691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy.
    Myers MG; Leenen FH; Burns R; Frankel D
    Clin Pharmacol Ther; 1986 Apr; 39(4):409-13. PubMed ID: 2869849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB; Gonik B; Dorman KF
    Surg Gynecol Obstet; 1985 Sep; 161(3):240-4. PubMed ID: 4035539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive action of verapamil in a group of hydralazine-dependent hypertensive patients.
    González-Gómez A; Gamio-Capestany F; García-Barreto D
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):268-77. PubMed ID: 6838286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydralazine and prazosin in the treatment of hypertension.
    Vandenburg MJ; Sharman VL; Wright P; Drew PJ; Barnes JN
    Br J Clin Pharmacol; 1983 Nov; 16(5):537-42. PubMed ID: 6357257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients.
    Jackson SH; Shepherd AM; Ludden TM; Jamieson MJ; Woodworth J; Rogers D; Ludden LK; Muir KT
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):624-8. PubMed ID: 1706804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioassay of the vasodepressor and cardiostimulatory effects of hydralazine and pyridazine derivative (DL-150) in hypertensive patients.
    Pasotti C; Nicrosini F; Marchetti M; Manzini A; Nicolis FB
    Farmaco Prat; 1976 Sep; 31(9):453-62. PubMed ID: 1010019
    [No Abstract]   [Full Text] [Related]  

  • 35. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravenous dose on hydralazine kinetics after administration.
    Ludden TM; Shepherd AM; McNay JL; Lin MS
    Clin Pharmacol Ther; 1983 Aug; 34(2):148-52. PubMed ID: 6872407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined clonidine and hydralazine therapy in severe and refractory hypertension.
    Velasco M; Guevara J; Urbina-Quintana A; Hernández-Pieretti O
    Acta Cient Venez; 1977; 28(5):342-5. PubMed ID: 602602
    [No Abstract]   [Full Text] [Related]  

  • 39. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.